Brief: Heat Biologics Announces New Preclinical Data On Ptx-35, Demonstrating Decreased Regulatory T-Cell (Treg) Activity And Delayed Tumor Progression
12/04/2021 15:25
April 12 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS - ANNOUNCES NEW PRECLINICAL DATA ON PTX-35,
DEMONSTRATING DECREASED REGULATORY T-CELL (TREG) ACTIVITY AND
DELAYED TUMOR PROGRESSION
* HEAT BIOLOGICS INC - REPORTED THAT PROMISING NEW
PRECLINICAL
DATA OF PTX-35 IS PRESENTED AT AACR ANNUAL MEETING 2021
* HEAT BIOLOGICS INC - CONTINUE TO ADVANCE FIRST-IN-HUMAN
PHASE 1
STUDY OF PTX-35 IN PATIENTS WITH SOLID TUMORS
Source text - https://bit.ly/324HrkR
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company